InsidersTradesSigma
Discover the full record of transactions filed by Golembiewski Michael Joseph, Chief Financial Officer. Insider active across 1 companies, notably Seelos Therapeutics, INC.. In total, 1 filings have been published. The latest transaction was disclosed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Michael Joseph Golembiewski is the Chief Financial Officer of Seelos Therapeutics, Inc. In this role, he oversees the financial operations of the company, including budget planning and risk management. His expertise is essential to ensure the financial health and growth of the organization.